These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 16499078
1. [9-nitrocamptothecin nanostructured lipid carrier system: in vitro releasing characteristics, uptake by cells, and tissue distribution in vivo]. Li JC, Sha XY, Zhang LJ, Fang XL. Yao Xue Xue Bao; 2005 Nov; 40(11):970-5. PubMed ID: 16499078 [Abstract] [Full Text] [Related]
2. [Preparation of PEG-modified nanostructured lipid carriers loaded with hydroxycamptothecin and tissue distribution in mice]. Zhang XX, Gan Y, Yang XG, Zhu CL, Gan L, Nie SF, Pan WS. Yao Xue Xue Bao; 2008 Jan; 43(1):91-6. PubMed ID: 18357740 [Abstract] [Full Text] [Related]
3. Biodistribution in mice and severity of damage in rat lungs following pulmonary delivery of 9-nitrocamptothecin liposomes. Zhang LJ, Xing B, Wu J, Xu B, Fang XL. Pulm Pharmacol Ther; 2008 Jan; 21(1):239-46. PubMed ID: 17561423 [Abstract] [Full Text] [Related]
4. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying. Zhang X, Pan W, Gan L, Zhu C, Gan Y, Nie S. Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233 [Abstract] [Full Text] [Related]
5. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine. Su Z, Niu J, Xiao Y, Ping Q, Sun M, Huang A, You W, Sang X, Yuan D. Mol Pharm; 2011 Oct 03; 8(5):1641-51. PubMed ID: 21770405 [Abstract] [Full Text] [Related]
6. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation. Liu X, Zhang Z, Jiang Y, Hu Y, Wang Z, Liu J, Feng R, Zhang J, Huang G. Drug Deliv; 2015 Feb 03; 22(2):223-9. PubMed ID: 24559497 [Abstract] [Full Text] [Related]
10. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells. Zhou J, Sun M, Jin S, Fan L, Zhu W, Sui X, Cao L, Yang C, Han C. Drug Deliv; 2019 Dec 03; 26(1):281-289. PubMed ID: 30880491 [Abstract] [Full Text] [Related]
14. Preparation and characterization of 10-hydroxycamptothecin loaded nanostructured lipid carriers. Liu K, Sun J, Wang Y, He Y, Gao K, He Z. Drug Dev Ind Pharm; 2008 May 03; 34(5):465-71. PubMed ID: 18473227 [Abstract] [Full Text] [Related]
15. Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity. Shi B, Fang C, Pei Y. J Pharm Sci; 2006 Sep 03; 95(9):1873-87. PubMed ID: 16795003 [Abstract] [Full Text] [Related]
16. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Yuan H, Wang LL, Du YZ, You J, Hu FQ, Zeng S. Colloids Surf B Biointerfaces; 2007 Nov 15; 60(2):174-9. PubMed ID: 17656075 [Abstract] [Full Text] [Related]